Angiotensin blockade inhibits increased JNKs, AP-1 and NF- kappa B DNA-binding activities in myocardial infarcted rats.

Inhibition of the renin-angiotensin system has been shown to prevent left ventricular remodeling after myocardial infarction. However, the effect of angiotensin on the signal transduction pathway of left ventricular remodeling after myocardial infarction is as yet unknown. The purpose of this study was to measure myocardial MAPKs and AP-1, NF- kappa B, and Sp-1 DNA-binding activities after myocardial infarction. Moreover, we evaluated the effects of angiotensin converting enzyme (ACE) inhibitor and angiotensin receptor blocker (ARB) on signal transduction pathway. Myocardial infarction was produced by ligation of the coronary artery in Wistar rats. Temocapril (ACE inhibitor) (3 and 30 mg/kg/day) and candesartan cilexitil (ARB) (1 and 10 mg/kg/day) were orally administered once a day. After ligation of the left descending coronary artery, JNKs (p46JNK and p55JNK) increased to 2.0- (P<0.01) and 2.8-fold (P<0.01) at 7 days, respectively. ERKs (p44ERK and p42ERK) and p38 activities did not increase significantly. AP-1 and NF- kappa B binding activities increased at 5 days, reached their peak 2.2- and 2.0-fold at 7 days. Sp-1 did not change. ACE inhibitor and ARB inhibited JNKs, NF- kappa B and AP-1 activities. Increased JNKs, AP-1, NF- kappa B, and Sp-1 DNA-binding activities were suppressed by both drugs in the infarcted region. Doppler-echocardiography showed that ACE inhibitor and ARB prevented the dilatation of left ventricular cavity at 14 days and improved diastolic filling pattern. JNKs, AP-1 and NF- kappa B activation in myocardial infarcted rats could be responsible for left ventricular remodeling after myocardial infarction and angiotensin may be related to the activation of these signals.

[1]  Shokei Kim,et al.  Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. , 2000, Pharmacological reviews.

[2]  J. Guerrero,et al.  Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH(2)-terminal kinases. , 1999, The Journal of clinical investigation.

[3]  Shokei Kim,et al.  Activation of mitogen-activated protein kinases in in vivo ischemia/reperfused myocardium in rats. , 1999, Journal of molecular and cellular cardiology.

[4]  Shokei Kim,et al.  Effects of candesartan and cilazapril on rats with myocardial infarction assessed by echocardiography. , 1999, Hypertension.

[5]  H. Matsubara,et al.  Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. , 1998, Circulation research.

[6]  Shokei Kim,et al.  Differential activation of cardiac c-jun amino-terminal kinase and extracellular signal-regulated kinase in angiotensin II-mediated hypertension. , 1998, Circulation research.

[7]  A. Matsumori,et al.  Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. , 1998, Circulation.

[8]  Jiahuai Han,et al.  Cardiac Hypertrophy Induced by Mitogen-activated Protein Kinase Kinase 7, a Specific Activator for c-Jun NH2-terminal Kinase in Ventricular Muscle Cells* , 1998, The Journal of Biological Chemistry.

[9]  Y. Mori,et al.  Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. , 1997, Circulation.

[10]  R. Carey,et al.  The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. , 1997, The Journal of clinical investigation.

[11]  F. Neumann,et al.  Induction of cytokine expression in leukocytes in acute myocardial infarction. , 1997, Journal of the American College of Cardiology.

[12]  K. Chien,et al.  The MEKK-JNK Pathway Is Stimulated by α1-Adrenergic Receptor and Ras Activation and Is Associated with in Vitroand in Vivo Cardiac Hypertrophy* , 1997, The Journal of Biological Chemistry.

[13]  O. Carretero,et al.  Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. , 1997, The Journal of clinical investigation.

[14]  G. Booz,et al.  Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy. , 1996, Hypertension.

[15]  J. Avruch,et al.  Stress-activated protein kinases in cardiovascular disease. , 1996, Circulation research.

[16]  Y. Yazaki,et al.  Mechanical stretch activates the stress‐activated protein kinase in cardiac myocytes , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  R. Morishita,et al.  The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Gómez-Lechón,et al.  Cytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6. , 1995, The American journal of physiology.

[19]  M. Karin.  The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases (*) , 1995, The Journal of Biological Chemistry.

[20]  X. Xu,et al.  Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. , 1995, Hypertension.

[21]  T. Kishimoto,et al.  Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Paul,et al.  The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. , 1995, The Journal of clinical investigation.

[23]  R. Davis,et al.  MAPKs: new JNK expands the group. , 1994, Trends in biochemical sciences.

[24]  L Bibbs,et al.  A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. , 1994, Science.

[25]  J. Woodgett,et al.  The stress-activated protein kinase subfamily of c-Jun kinases , 1994, Nature.

[26]  M. Karin,et al.  JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain , 1994, Cell.

[27]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[28]  Y. Yazaki,et al.  Control of cardiac gene expression by mechanical stress. , 1993, Annual review of physiology.

[29]  K. Webster,et al.  Positive regulation of the skeletal alpha-actin gene by Fos and Jun in cardiac myocytes. , 1992, The Journal of biological chemistry.

[30]  P. Baeuerle.  The inducible transcription activator NF-κB: regulation by distinct protein subunits , 1991 .

[31]  E. Nishida,et al.  Microtubule-associated-protein (MAP) kinase activated by nerve growth factor and epidermal growth factor in PC12 cells. Identity with the mitogen-activated MAP kinase of fibroblastic cells. , 1990, European journal of biochemistry.

[32]  M. Sporn,et al.  Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex , 1990, Molecular and cellular biology.

[33]  M. Kohno,et al.  Circulating immunoreactive endothelin in ischemic heart disease. , 1990, American heart journal.

[34]  M. Pfeffer,et al.  Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications , 1990, Circulation.

[35]  S. Whitebread,et al.  Preliminary biochemical characterization of two angiotensin II receptor subtypes. , 1989, Biochemical and biophysical research communications.

[36]  M. Karin,et al.  Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor , 1987, Cell.

[37]  D. Baltimore,et al.  In vitro transcription of immunoglobulin genes in a B-cell extract: effects of enhancer and promoter sequences. , 1987, Molecular and cellular biology.

[38]  David Baltimore,et al.  Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism , 1986, Cell.

[39]  M. Fishbein,et al.  Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. , 1978, The American journal of pathology.